MORI-BUILDING
24.1.2023 03:01:40 CET | Business Wire | Press release
Mori Building Co., Ltd., Japan’s leading urban landscape developer, announced today that the 49-story Toranomon Hills Station Tower will open this coming autumn. This project is being led by the Toranomon 1 & 2-chome District Urban Redevelopment Association, in which Mori Building is a leading participant. With the birth of Toranomon Hills Station Tower, which currently is being thoroughly integrated with Toranomon Hills Station, the entire Toranomon Hills area, which has been expanding and evolving at an unprecedented speed toward the realization of a new international hub and global business center, will be completed as a “city” boasting a scale and impact comparable to that of Roppongi Hills.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230123005232/en/
Completion image of Toranomon Hills (Note: please be sure to state the copyright “©The Boundary” when using this image.) (Graphic: Business Wire)
Toranomon Hills Station Tower is a multi-purpose 266-meter high tower with 49 floors above ground and 4 floors underground. By integrating the overall development with Toranomon Hills Station on the Tokyo Metro Hibiya Line, the tower will be complemented by a large and bustling station plaza and a pedestrian deck measuring 20 meters in width above Sakurada-dori Avenue (National Route 1), offering access to Toranomon Hills Mori Tower Oval Square. By strengthening and expanding the local multilevel transportation network on the ground, underground and the deck-level, the Station Tower will greatly enhance the Toranomon Hills as a transportation node and will enliven the entire area by significantly improving pedestrian flows.
The Station Tower will offer world-class office, as well as retail facilities integrated with the station plaza and a hotel making its debut in Tokyo. The tower‘s top-most level will be home to TOKYO NODE, an interactive communication facility consisting of halls, galleries, pool, restaurants, and other facilities fully capable of creating new values, ideas and business transcending domains, aimed at sharing creativity with the world.
The Toranomon Hills will be expanded to 7.5ha and total floor space of 800,000m2 with the opening of Toranomon Hills Station Tower in autumn, 2023. The area is steadily evolving as a mixed‐use complex integrated with urban infrastructures such as road and subway, with an impact comparable to that of Mori Building's epoch-making Roppongi Hills.
Open and Lively “Station Atrium” Created through Integrated Development of Station and Neighborhood
The Station Atrium (2,000m2) is a three-story atrium-style vaulted space combining coordinated and complementary urban and transportation functions.
The Station Atrium’s direct connections between the station plaza and nearby facilities for events and shopping keep the space bustling with a steady flow of people from morning till night.
20m-wide Large-scale Pedestrian T-Deck above Arterial Road
The 20m-wide large-scale pedestrian T-deck above Sakurada-dori Avenue (National Route 1) and connected to Toranomon Hills Mori Tower’s Oval Square. The elevated walkway, which passes through the Station Tower, is the main route for east-west pedestrian traffic, crossing districts and arterial road. It realizes safe urban spaces by separating pedestrians and vehicles in the area, and will function as a square linking people in Toranomon Hillls.
Interactive Communication Facility Connecting Tokyo with the World: TOKYO NODE
Toranomon Hills Station Tower’s top floors (45th to 49th floors, partly 8th) will be a home to TOKYO NODE, a 10,000m2 interactive communication facility.
Main hall and three galleries can be used individually or integrated as one contiguous venue. On the rooftop, sky garden, pool, and two restaurants curated by world-class chefs will open, including a grill restaurant supervised by Kei Kobayashi, the first Asian chef to earn three Michelin stars in Paris. The laboratory on the 8th floor, will further enhance the facility’s capacity as a highly functional and distinctive space for communication and knowledge-sharing, wholly unlike traditional conference and banquet facilities.
Furthermore, TOKYO NODE will serve as an information dissemination platform of for the entire Toranomon Hills area, allowing Toranomon Hills to evolve into a “communication hub” that attracts highly experienced and influential people from throughout the world for business creation and innovation to share globally.
New Office Space for Connecting People
Responding to Diverse Needs and New Workstyles
Office area located on 9th, 10th, 15-44th floors (total 32 floors), offers a total rental area measuring some 107,000 m2 and standard floors of about 3,400m2, including column-free plans with depths from core to window surface of about 18.5m, accommodate diverse workstyles and other needs of global companies.
In addition, eight "magnet zones" are equipped with atrium spaces and staircases, connecting the upper and lower floors to promote communication and collaboration among workers, and create more dynamic and creative workplaces.
Retail Facilities Support Global Players’ Work and Lives
A retail space measuring about 14,400m2 will occupy nine floors (B2-7th) with some 80 stores that support the work and lives of global players including office workers and residents.
The T‐Market (27 shops, approx. 3,000m2) will be full of life from morning till night (7am to 11pm) with restaurants, delis and stores. The restaurants will offer high-quality but reasonably priced menus, many curated by highly acclaimed chefs and pâtissiers, including some with Michelin or Bib Gourmand credentials.
Hotel Toranomon Hills: Tokyo's First Unbound Collection by Hyatt
The 1st floor and 11th to 14th floors will be home to the Hotel Toranomon Hills with 205 guest rooms including standard rooms measuring about 27m2 to 34m2. The hotel brand is “The Unbound Collection by Hyatt,” which will be making its debut in Tokyo as a part of “Independent Collection.”
It will serve as an “urban living room of Toranomon” welcoming a variety of guests with its restaurant, cafe and lounges open to the city.
All food and beverage experiences in the hotel‘s café and restaurant will be supervised by Sergio Herman,. Herman is a native of the Netherlands and longtime Michelin-starred chef and this will be his first foray into Japan.
World-leading Architects, Designers and Artists
- Design: Shohei Shigematsu (OMA)
The Design of Toranomon Hills Station Tower is OMA’s first large-scale architectural project in Tokyo.
Its design is based on ”THE ACTIVITY BAND” concept, or urban axis running from Shintora-dori Avenue to the Akasaka/Toranomon area, creating a symbolic place for people to gather and interact along the axis.
- Hotel Design (interior): Space Copenhagen
The hotel interior design is by Space Copenhagen, a Denmark Interior design firm, which will be their first interior design in Japan.
Multiple Global Environmental Certifications Received
Toranomon Hills area received preliminary Platinum certification, the highest rank in the LEED program’s ND category.
Station Tower’s offices and retail facilities have received preliminary Platinum certification in the BD+C:CS category and WELL preliminary certification and are expected to earn top Platinum certification once completed. It is Japan’s second largest precertified property, following the Azabudai Hills.
In addition, Station Tower will be 100% powered by RE100-compliant renewable energy from the time of its completion.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230123005232/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
